Literature DB >> 33724992

Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.

Mehd Abdu1, Yeshimebet Ali2, Samuel Anteneh3, Mohammed Yesuf1, Adane Birhanu4, Salih Mohamed5, Adem Hussien3.   

Abstract

INTRODUCTION: Globally, tuberculosis takes the first rank for the ill-health of people living with HIV/AIDS. Despite the favorable outcome of antiretroviral therapy, the risk of tuberculosis remains higher among HIV patients. This obliges to identify factors for its occurrence and further prevention of drug-resistant tuberculosis. There is a contradiction between different studies and studies conducted in Ethiopia studied poorly the association between adherence to antiretroviral therapy and viral load with tuberculosis. Studies conducted in the study area were limited to cross-sectional study design. Therefore, this study claimed to identify factors determining the occurrence of tuberculosis after initiation of antiretroviral therapy.
METHODS: This study was conducted at Dessie Referral Hospital by using a case-control study design on a sample of 565 with a control: case ratio of 3:1. Participants from controls were selected by systematic random sampling and from cases by consecutive random sampling. The data were collected by interviewing through structured questionnaires and from the medical record. The data were entered into Epi data version 3.1. In the multivariable analysis, variables with a P-value of ≤0.05 were anticipated as independent determinant factors. RESULT: Patients without separate kitchen (AOR: 3.547, 95% CI: 2.137, 5.888), having opportunistic infection (AOR: 3.728, 95% CI: 2.058, 6.753), CD4 count of <350 cells/mm3 (AOR: 3.383, 95% CI: 1.520, 7.528), baseline WHO stage III (AOR: 3.321, 95% CI: 1.688, 6.534) or IV (AOR: 2.900, 95% CI: 1.251, 6.722), don't taking IPT (AOR: 3.701, 95% CI: 2.228, 6.147) and those who were poorly adherent (AOR: 2.626, 95% CI: 1.272, 5.423) or moderately adherent (AOR: 3.455, 95% CI: 1.885, 6.335) to anti-retroviral therapy were more likely to develop tuberculosis after anti-retroviral therapy initiation.
CONCLUSION: Poor housing conditions, having an opportunistic infection, low CD4 count, starting ART at the advanced HIV stage, don't take IPT, and being poorly adherent to antiretroviral therapy were associated with the occurrence of TB after initiation of ART. The institution should screen for TB as early as possible and strictly follow their drug adherence.

Entities:  

Year:  2021        PMID: 33724992     DOI: 10.1371/journal.pone.0248490

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  4 in total

1.  Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study.

Authors:  Amare Getu; Haileab Fekadu Wolde; Yaregal Animut; Anteneh Ayelign Kibret
Journal:  PLoS One       Date:  2022-08-03       Impact factor: 3.752

2.  Incidence and Predictors of Pulmonary Tuberculosis among Children Who Received Antiretroviral Therapy (ART), Northwest Ethiopia: A Multicenter Historical Cohorts Study 2009-2019.

Authors:  Fassikaw Kebede; Habtamu Tarekegn; Mulugeta Molla; Dube Jara; Abebe Abate
Journal:  J Trop Med       Date:  2022-01-29

3.  Nonadherence Predictors to Tuberculosis Medications among TB Patients in Gambella Region of Ethiopia.

Authors:  Taye Kebede; Wiw Gach Jing; Abiot Girma; Kifle Woldemichael
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-08-24       Impact factor: 2.585

4.  Bayesian parametric modeling of time to tuberculosis co-infection of HIV/AIDS patients at Jimma Medical Center, Ethiopia.

Authors:  Abdi Kenesa Umeta; Samuel Fikadu Yermosa; Abdisa G Dufera
Journal:  Sci Rep       Date:  2022-10-01       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.